Trial reportDepression and anxiety2026
Depression, Nutritional Status, and Substance P/NK-1R Biomarkers in Dysmenorrhea: A Randomized Crossover Trial.
Trial report in Depression and anxiety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Substance P SP and neurokinin‐1 receptor NK‐1R as biomarkers of pain and stress: SP and NK-1R are neuropeptide related biomarkers involved in nociceptive pathways. Dysmenorrhea is frequently associated with psychological distress and biochemical alterations; however, their interrelationship across treatment phases remains insufficiently understood. Objectives: To explore changes in psychological status (depression, anxiety, and stress), nutritional status, and SP/NK-1R-related biomarker levels across NSAID and dexamethasone plus aprepitant combination therapy phases in females with dysmenorrhea. Methods: This was a randomized, sequential, within-subject repeated-measures crossover exploratory controlled trial with a parallel healthy control group. A total of 40 females were enrolled, including 30 with primary dysmenorrhea and 10 healthy controls. Dysmenorrhea participants were assessed over three menstrual cycles across three phases: baseline (no treatment), NSAID phase (ibuprofen 400 mg three times daily for 3 days), and combination therapy phase (dexamethasone plus aprepitant for 2 days). Psychological status was assessed using DASS-21, and nutritional status using the mini nutritional assessment (MNA). Serum SP and NK-1R levels were measured using ELISA in a subset of participants due to sample limitations. Data were analyzed using IBM SPSS Statistics (version 22), with repeated-measures ANOVA and independent Results: Participants with dysmenorrhea were enrolled and assessed for ELISA based SP levels in blood. SP levels showed significant variation across treatment phases ( Conclusion: This study demonstrates phase-dependent changes in SP levels alongside psychological and nutritional variations in women with dysmenorrhea. However, absence of clinical pain outcomes and small subgroup sizes limit causal interpretation, and findings should be considered preliminary and biomarker-focused.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.